Sabine Schmid
Brief Report: Pembrolizumab as palliative immunotherapy in malignant pleural mesothelioma
Metaxas Y, Froesch P, Löffler-Baumann M, Pratsch-Peter S, Russell P, Mingrone W, Savic S, Thapa B, Früh M, Pless M, von Moos R, Mauti L, O'Byrne K, Petrausch U, Wolleb S, Rivalland G, Klingbiel D, Kao S, Schmid S, Nowak A, Gautschi O, Bartnick T, Hughes B, Bouchaab H, Rothschild S, Pavlakis N, John T. Brief Report: Pembrolizumab as palliative immunotherapy in malignant pleural mesothelioma. J Thorac Oncol 2018
21.08.2018Brief Report: Pembrolizumab as palliative immunotherapy in malignant pleural mesothelioma
21.08.2018J Thorac Oncol 2018
Metaxas Yannis, Froesch Patrizia, Löffler-Baumann Melanie, Pratsch-Peter Susanne, Russell Prudence, Mingrone Walter, Savic Spasenija, Thapa Bibhusal, Früh Martin, Pless Miklos, von Moos Roger, Mauti Laetitia, O'Byrne Kenneth, Petrausch Ulf, Wolleb Sybille, Rivalland Gareth, Klingbiel Dirk, Kao Steven, Schmid Sabine, Nowak Anna K, Gautschi Oliver, Bartnick Tammo, Hughes Brett G, Bouchaab Hasna, Rothschild Sacha, Pavlakis Nick, John Thomas
Immune checkpoint inhibitors and small cell lung cancer: what's new?
Schmid S, Früh M. Immune checkpoint inhibitors and small cell lung cancer: what's new?. J Thorac Dis 2018; 10:S1503-S1508.
01.05.2018Immune checkpoint inhibitors and small cell lung cancer: what's new?
01.05.2018J Thorac Dis 2018; 10:S1503-S1508
Schmid Sabine, Früh Martin
Is There a Flare Phenomenon on Bone Scintigraphy in Men With Advanced Prostate Cancer Treated With Radium-223?
Isensee G, Péporté A, Müller J, Schmid S, Gillessen Sommer S, Omlin A. Is There a Flare Phenomenon on Bone Scintigraphy in Men With Advanced Prostate Cancer Treated With Radium-223?. Clin Genitourin Cancer 2018; 16:349-354.
23.04.2018Is There a Flare Phenomenon on Bone Scintigraphy in Men With Advanced Prostate Cancer Treated With Radium-223?
23.04.2018Clin Genitourin Cancer 2018; 16:349-354
Isensee Gesa, Péporté Anne, Müller Joachim, Schmid Sabine, Gillessen Sommer Silke, Omlin Aurelius
Immune checkpoint inhibitors and small cell lung cancer: what’s new?
Schmid S, Früh M. Immune checkpoint inhibitors and small cell lung cancer: what’s new?. Journal of theoracic disease 2018; 10:1503-1508.
14.01.2018Immune checkpoint inhibitors and small cell lung cancer: what’s new?
14.01.2018Journal of theoracic disease 2018; 10:1503-1508
Schmid Sabine, Früh Martin
The role of radiation therapy in the management of small cell lung cancer
Glatzer M, Schmid S, Radovic M, Früh M, Putora P. The role of radiation therapy in the management of small cell lung cancer. Breathe (Sheff) 2017; 13:e87-e94.
01.12.2017The role of radiation therapy in the management of small cell lung cancer
01.12.2017Breathe (Sheff) 2017; 13:e87-e94
Glatzer Markus, Schmid Sabine, Radovic Marco, Früh Martin, Putora Paul Martin
Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab
Diem S, Schmid S, Krapf M, Flatz L, Born D, Jochum W, Templeton A, Früh M. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab. Lung Cancer 2017; 111:176-181.
24.07.2017Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab
24.07.2017Lung Cancer 2017; 111:176-181
Diem Stefan, Schmid Sabine, Krapf Mirjam, Flatz Lukas, Born Diana, Jochum Wolfram, Templeton Arnoud J, Früh Martin
Multiple primary tumours: challenges and approaches, a review
Vogt A, Schmid S, Heinimann K, Frick H, Herrmann C, Cerny T, Omlin A. Multiple primary tumours: challenges and approaches, a review. ESMO Open 2017; 2:e000172.
02.05.2017Multiple primary tumours: challenges and approaches, a review
02.05.2017ESMO Open 2017; 2:e000172
Vogt Alexia, Schmid Sabine, Heinimann Karl, Frick Harald, Herrmann Christian, Cerny Thomas, Omlin Aurelius
Clinical Outcome of ALK-Positive Non-Small Cell Lung Cancer (NSCLC) Patients with De Novo EGFR or KRAS Co-Mutations Receiving Tyrosine Kinase Inhibitors (TKIs)
Schmid S, Diebold J, Jochum W, Reichegger H, Klingbiel D, Froesch P, Mark M, Rothschild S, Gautschi O, Früh M. Clinical Outcome of ALK-Positive Non-Small Cell Lung Cancer (NSCLC) Patients with De Novo EGFR or KRAS Co-Mutations Receiving Tyrosine Kinase Inhibitors (TKIs). J Thorac Oncol 2016
19.12.2016Clinical Outcome of ALK-Positive Non-Small Cell Lung Cancer (NSCLC) Patients with De Novo EGFR or KRAS Co-Mutations Receiving Tyrosine Kinase Inhibitors (TKIs)
19.12.2016J Thorac Oncol 2016
Schmid Sabine, Diebold Joachim, Jochum Wolfram, Reichegger Hermann, Klingbiel Dirk, Froesch Patrizia, Mark Michael, Rothschild Sacha, Gautschi Oliver, Früh Martin
Assessment of Anticancer-Treatment Outcome in Patients with Metastatic Castration-Resistant Prostate Cancer - Going beyond PSA and Imaging, a Systematic Literature Review
Schmid S, Omlin A, Blum D, Strasser F, Gillessen Sommer S, Rothermundt C. Assessment of Anticancer-Treatment Outcome in Patients with Metastatic Castration-Resistant Prostate Cancer - Going beyond PSA and Imaging, a Systematic Literature Review. Ann Oncol 2015
27.07.2015Assessment of Anticancer-Treatment Outcome in Patients with Metastatic Castration-Resistant Prostate Cancer - Going beyond PSA and Imaging, a Systematic Literature Review
27.07.2015Ann Oncol 2015
Schmid Sabine, Omlin Aurelius, Blum D, Strasser Florian, Gillessen Sommer Silke, Rothermundt Christian
Management of von Hippel-Lindau Disease: An Interdisciplinary Review
Schmid S, Rothermundt C, Weber J, van Leyen K, Sulz M, Stöckli S, Krull I, Krek W, Kloos P, Heinimann K, Hader C, Greiner J, Engeler D, Brändle M, Binet F, Gillessen Sommer S, Hundsberger T. Management of von Hippel-Lindau Disease: An Interdisciplinary Review. Oncol Res Treat 2014; 37:761-771.
17.11.2014Management of von Hippel-Lindau Disease: An Interdisciplinary Review
17.11.2014Oncol Res Treat 2014; 37:761-771
Schmid Sabine, Rothermundt Christian, Weber Johannes, van Leyen Karin, Sulz Michael, Stöckli Sandro, Krull Ina, Krek Willy, Kloos Patrik, Heinimann Karl, Hader Claudia, Greiner Jeannette, Engeler Daniel, Brändle Michael, Binet Françoise-Isabelle, Gillessen Sommer Silke, Hundsberger Thomas
Abiraterone--what is wrong with the adrenal glands?
Schmid S, Fornaro J, Rothermundt C, Omlin A, Brändle M, Rupp N, Gillessen Sommer S. Abiraterone--what is wrong with the adrenal glands?. Clin Genitourin Cancer 2014; 12:e133-7.
04.02.2014Abiraterone--what is wrong with the adrenal glands?
04.02.2014Clin Genitourin Cancer 2014; 12:e133-7
Schmid Sabine, Fornaro Jürgen, Rothermundt Christian, Omlin Aurelius, Brändle Michael, Rupp Niels J, Gillessen Sommer Silke
Endobronchial ultrasound-guided transbronchial needle aspiration of an intravascular sarcoma metastasis
Dusemund F, Schneider T, Zeisel C, Rothermundt C, Kluckert T, Schmid S, Brutsche M. Endobronchial ultrasound-guided transbronchial needle aspiration of an intravascular sarcoma metastasis. Respiration 2013; 86:430-432.
24.09.2013Endobronchial ultrasound-guided transbronchial needle aspiration of an intravascular sarcoma metastasis
24.09.2013Respiration 2013; 86:430-432
Dusemund Frank, Schneider Tino, Zeisel Christoph, Rothermundt Christian, Kluckert Thomas, Schmid Sabine, Brutsche Martin
Pulmonary embolism in a patient with primary renal synovial sarcoma: the important differential diagnosis of tumor embolism and its therapeutic implications
Schmid S, Öhlschlegel C, Nagel W, Zeisel C, Müller J, Rothermundt C. Pulmonary embolism in a patient with primary renal synovial sarcoma: the important differential diagnosis of tumor embolism and its therapeutic implications. Case Rep Oncol 2013; 6:331-8.
22.06.2013Pulmonary embolism in a patient with primary renal synovial sarcoma: the important differential diagnosis of tumor embolism and its therapeutic implications
22.06.2013Case Rep Oncol 2013; 6:331-8
Schmid Sabine, Öhlschlegel Christian, Nagel Wolfgang, Zeisel Christoph, Müller Joachim, Rothermundt Christian